Candan İltemir DUVAN, Yasemin ARDIÇOĞLU, Nilgün Öztürk TURHAN, Fatma BOLKAN

The Effect of Isoflavones on Bone Mass and Bone Remodelling Markers in Postmenopausal Women

Aim: Recently, isoflavones have attracted attention for their potential roles in the prevention and treatment of estrogen-related osteoporosis. However, the optimal dosage and the components responsible for the favorable effects of isoflavones on bone in humans are still unclear. This study aims to investigate the effect of low-dose isoflavones on bone mineral density (BMD) and on biochemical markers of bone turnover in early postmenopausal women. Materials and Methods: Ninety participants between 42-59 years of age were randomly assigned to receive twice a day either isoflavone tablet (n:45) that provided 29.8 mg genistein, 7.8 mg daidzein, and 2.4 mg glycitein per tablet or placebo tablets (n:45) containing 250 mg starch. BMD was measured both in lumbar spine and hip, and bone biomarkers of serum osteocalcin, serum alkaline phosphatase (ALP) and serum C-terminal telopeptide (CTX) were measured at baseline and after six months of therapy at the end of the study. Results: Isoflavone treatment after six months significantly increased BMD of L2-4 T score (+19%, p=0.000) and Ward triangle T score (+20%, p=0.000); femur neck T score (+4%, p=0.06) was also increased but this change did not reach a level of statistical significance. Serum CTX level (-25%, p=0.047) decreased in the isoflavone group, while osteocalcin (-8.3%, p=0.23) and ALP levels (+ 4.5%, p=0.43) showed no change. Conclusions: Isoflavone increases BMD of L2-4 and Ward triangle T scores at a dosage of 59.6 mg genistein with 15.6 mg daidzein and reduces bone resorption in early postmenopausal women.

Anahtar Kelimeler:

Isoflavone, genistein, bone mineral density, osteocalcin, serum C-terminal telopeptides

The Effect of Isoflavones on Bone Mass and Bone Remodelling Markers in Postmenopausal Women

Keywords:

Isoflavone, genistein, bone mineral density, osteocalcin, serum C-terminal telopeptides,

PDF

___

Yamaguchi M, Gao YH. Anabolic effect of genistein and genistin on bone metabolism in the femoral-metaphyseal tissues of elderly rats: the genistein effect is enhanced by zinc. Mol Cell Biochem. 1998; 178(1-2): 377-82.
Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998; 12(4): 543-57. Review.
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996; 126(1): 161-7.
Arjmandi BH, Smith BJ. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 2002; 13(3): 130-7.
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68(6 Suppl): 1375S-9S.
Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88(10): 4740-7.
Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004; 292(1): 65-74.
Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994; 124: 825-32.
Sugimoto E, Yamaguchi M. Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem Pharmacol 2000; 59(5): 471-5.
Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997; 138(10): 4509-12.
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138(3): 863-70.
Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996; 61(4): 629-37.
Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999; 2(4): 489-504. Review.
Watson CS, Pappas TC, Gametchu B. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect 1995; 103 (Suppl 7): 41-50.
Gao YH, Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 2000; 5(3): 261-7.
Mori M, Sagara M, Ikeda K, Miki T, Yamori Y. Soy isoflavones improve bone metabolism in postmenopausal Japanese women. Clin Exp Pharmacol Physiol 2004; 31 (Suppl 2): S44-6.
Camozzi V, Tossi A, Simoni E, Pagani F, Francucci CM, Moro L. Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 2007; 30(6 Suppl): 13-7.
Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001; 86(11): 5217-21.
Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002; 42(4): 295-300.
Ettinger B, Genant HK, Steiger P, Madvig P. Low-dosage micronized 17-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992; 166: 479–88.
Odell WE, Heath H. Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. Dis Mon 1993; 19: 789–98.
Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD. Calcium nutrition and bone health in the elderly. Am J Clin Nutr 1982; 36 (5 Suppl): 986–1013.
Dempster DW. Bone remodeling. In: Coe FL, Favus MJ, editors. Disorders of Bone and Mineral Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. pp. 315–44.